Ruxolitinib Powder
English synonyms:Jakafi;Roxolitinib
CAS NO.:941678-49-5
Molecular formula：C17H18N6
Purity & Grade: 99% HPLC; Medicine grade
MOQ & Package: 10g or 100g; Package according to demand
Shipping: DHL/FedEx/UPS/USPS Safe and fast delivery
Store & Shelf life: Cool & dry place; 24 months
Lead Time: 1-3 days
Warehouse: USA and Germany warehouse
Certificate:COA; HPLC; MSDS; TDS,etc.
- Product Description
Xi'an Faithful BioTech Co., Ltd: Your Trusted Ruxolitinib Powder Manufacturer & Supplier
As a leading Ruxolitinib powder manufacturer and supplier, Xi'an Faithful BioTech Co., Ltd offers superior quality, competitive pricing, and unmatched customer service. Our cGMP-certified facilities and rigorous quality control ensure consistent purity and potency in every batch of product we produce.
Ruxolitinib Powder Introduction
Ruxolitinib powder is potent JAK1/JAK2 inhibitor, is revolutionizing the treatment of myelofibrosis and polycythemia vera. Our pharmaceutical-grade product boasts exceptional purity (>98%) and meets stringent pharmacopeia standards, including USP, EP, and JP. At Xi'an Faithful BioTech, we understand the critical role Ruxolitinib plays in managing these challenging hematological disorders. Our advanced manufacturing processes and state-of-the-art equipment ensure consistent quality and stability across all batches. This reliability is crucial for pharmaceutical companies developing life-changing medications. Our product is meticulously tested to guarantee its efficacy and safety. We provide comprehensive documentation, including Certificates of Analysis (COA) and Material Safety Data Sheets (MSDS), to support your regulatory compliance needs. With our product, you're not just purchasing a product; you're investing in a partnership dedicated to advancing patient care.
Specifications
| Item | Specification | Results |
| Appearance | White to light-yellow crystalline powder | light-yellow |
| Identification | HPLC | Conforms |
| Related substances | Impurity B≤0.1% | 0.01% |
| Impurity C≤0.1% | ND | |
| Impurity D≤0.1% | ND | |
| Impurity E≤0.1% | 0.01% | |
| Any single unknown impurity≤0.1% | 0.17% | |
| Total impurities ≤1.0% | 0.24% | |
| Optical isomers | Impurity A≤1.0% | 0.57% |
| Loss on Drying | ≤0.50% | 0.40% |
| Residual solvents | Methanol≤0.3% | Conforms |
| Isopropyl alcohol≤0.5% | Conforms | |
| MTBE≤0.5% | Conforms | |
| EA≤0.5% | Conforms | |
| THF ≤0.072% | Conforms | |
| 1, 4 – dioxane ≤0.038% | Conforms | |
| DMSO ≤0.5% | Conforms | |
| Purity | ≥99.0% | 99.70% |
| Conclusion：Conform with enterprise specification | ||
Why Choose Us?
- Quality Assurance: Our cGMP-certified facilities and ISO 9001 accreditation guarantee top-tier Ruxolitinib powder.
- Customization: We offer tailored solutions to meet your specific requirements, including custom synthesis and packaging options.
- Regulatory Support: Our experienced team assists with documentation and compliance, streamlining your regulatory processes.
- Research Expertise: Our dedicated R&D department continually explores new applications and improvements for product.
- Supply Chain Reliability: With our efficient production and robust logistics network, we ensure consistent availability and timely delivery.
- Competitive Pricing: Our scale of operations allows us to offer attractive pricing without compromising on quality.
- Technical Support: Our team of experts provides comprehensive application and formulation assistance.
Application Areas
- Myelofibrosis Treatment: It is a cornerstone in managing this rare bone marrow disorder, helping to reduce spleen size and alleviate symptoms.
- Polycythemia Vera Therapy: Our high-purity product is crucial in developing treatments for this slow-growing blood cancer, helping to control red blood cell production.
- Oncology Research: Researchers use our product to explore its potential in treating various cancers, leveraging its JAK inhibition properties.
- Dermatological Applications: Emerging studies suggest Ruxolitinib's efficacy in treating certain skin conditions, opening new avenues for dermatological product development.
- Autoimmune Disease Research: The immunomodulatory effects of Ruxolitinib make it a subject of interest in autoimmune disorder studies.
- Pharmaceutical Formulations: Our product is ideal for developing oral tablets, topical formulations, and other drug delivery systems.
Quality Control
Our state-of-the-art quality control processes ensure the highest standards for every batch of Ruxolitinib powder.
R&D Results
Our ongoing research continues to uncover new potential applications for product.
Packaging and Transportation
We offer flexible packaging options and ensure proper storage conditions during transportation.
After-sales Service
Our dedicated customer support team is available 24/7 to address any queries or concerns.
Qualification Certification
Transaction Feedback
Our customers consistently praise our product quality and service reliability.
Exhibition
We regularly participate in international pharmaceutical exhibitions to showcase our product.
FAQ
Q1: What is the minimum order quantity for product?
A1: We offer flexible MOQs to accommodate various needs. Please contact us for specific details.
Q2: How do you ensure the consistency of product across batches?
A2: Our advanced manufacturing processes and stringent quality control measures guarantee batch-to-batch consistency.
Q3: Can you provide stability data for your product?
A3: Yes, we offer comprehensive stability data. Please reach out to our technical support team for detailed information.
Q4: What is the lead time for Ruxolitinib powder orders?
A4: Typical lead times range from 2-4 weeks, depending on order volume. We can discuss expedited options if needed.
Q5: Do you offer technical support for product applications?
A5: Absolutely! Our team of experts is available to assist with application development and troubleshooting.
Contact Us
For inquiries about our Ruxolitinib powder or to request a quote, please contact us at allen@faithfulbio.com. Our team is ready to provide you with the information and support you need to make an informed decision.
